Zhitong Finance App News, Laimei Pharmaceutical (300006.SZ) issued an announcement. Recently, the company received the “Drug Registration Certificate” for acetylcysteine solution (3ml: 0.3 g) for inhalation approved and issued by the State Drug Administration. Obtaining a “Drug Registration Certificate” for acetylcysteine solution for inhalation will help further enrich the company's product line and enhance the company's competitiveness.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.